Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEUTHREE: Eflapegrastim Administration Timing in Breast Cancer
NCT05949333Phase 4Recruiting
- Sponsor
- Good Gang-An Hospital
- Start
- Nov 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esketamine in neutropenia, sponsored by Good Gang-An Hospital. Started Nov 2023; status: recruiting.
02
Drugs
esketamine
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT05949333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05949333.